JUVISYNC Trademark

Trademark Overview


On Friday, October 31, 2025, a trademark application was filed for JUVISYNC with the United States Patent and Trademark Office. The USPTO has given the JUVISYNC trademark a serial number of 99473552. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Monday, March 16, 2026. This trademark is owned by Adventapharma DWC LLC. The JUVISYNC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diabetes
juvisync

General Information


Serial Number99473552
Word MarkJUVISYNC
Filing DateFriday, October 31, 2025
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateMonday, March 16, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkJUVI SYNC
Goods and ServicesPharmaceutical preparations for the treatment of diabetes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 31, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAdventapharma DWC LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDubai Marina
AE

Trademark Events


Event DateEvent Description
Friday, October 31, 2025NEW APPLICATION ENTERED
Friday, October 31, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 31, 2025APPLICATION FILING RECEIPT MAILED
Monday, March 16, 2026ASSIGNED TO EXAMINER